SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001873919-24-000001
Filing Date
2024-10-03
Accepted
2024-10-03 18:19:19
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9995
  Complete submission text file 0001873919-24-000001.txt   12002
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494
Business Address
Aguilar Laura K. (Reporting) CIK: 0001873915 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 241352943

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494
Business Address
Aguilar-Cordova Estuardo (Reporting) CIK: 0001873919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 241352944